11 results on '"Garavelli, Silvia"'
Search Results
2. T Cells: Warriors of SARS-CoV-2 Infection
- Author
-
de Candia, Paola, Prattichizzo, Francesco, Garavelli, Silvia, and Matarese, Giuseppe
- Published
- 2021
- Full Text
- View/download PDF
3. Plasma circulating miR-23~27~24 clusters correlate with the immunometabolic derangement and predict C-peptide loss in children with type 1 diabetes
- Author
-
Garavelli, Silvia, Bruzzaniti, Sara, Tagliabue, Elena, Di Silvestre, Dario, Prattichizzo, Francesco, Mozzillo, Enza, Fattorusso, Valentina, La Sala, Lucia, Ceriello, Antonio, Puca, Annibale A., Mauri, Pierluigi, Strollo, Rocky, Marigliano, Marco, Maffeis, Claudio, Petrelli, Alessandra, Bosi, Emanuele, Franzese, Adriana, Galgani, Mario, Matarese, Giuseppe, and de Candia, Paola
- Published
- 2020
- Full Text
- View/download PDF
4. Type 1 Diabetes and Associated Cardiovascular Damage: Contribution of Extracellular Vesicles in Tissue Crosstalk.
- Author
-
Garavelli, Silvia, Prattichizzo, Francesco, Ceriello, Antonio, Galgani, Mario, and de Candia, Paola
- Subjects
- *
TYPE 1 diabetes , *EXTRACELLULAR vesicles , *ISLANDS of Langerhans , *HYPERGLYCEMIA , *DIABETIC angiopathies , *DIABETES complications , *BLOOD sugar - Abstract
Significance: Type 1 diabetes (T1D) is characterized by the autoimmune destruction of the insulin secreting β-cells, with consequent aberrant blood glucose levels. Hyperglycemia is the common denominator for most of the chronic diabetic vascular complications, which represent the main cause of life reduction in T1D patients. For this disease, three interlaced medical needs remain: understanding the underlying mechanisms involved in pancreatic β-cell loss; identifying biomarkers able to predict T1D progression and its related complications; recognizing novel therapeutic targets. Recent Advances: Extracellular vesicles (EVs), released by most cell types, were discovered to contain a plethora of different molecules (including microRNAs) with regulatory properties, which are emerging as mediators of cell-to-cell communication at the paracrine and endocrine level. Recent knowledge suggests that EVs may act as pathogenic factors, and be developed into disease biomarkers and therapeutic targets in the context of several human diseases. Critical Issues: EVs have been recently shown to sustain a dysregulated cellular crosstalk able to exacerbate the autoimmune response in the pancreatic islets of T1D; moreover, EVs were shown to be able to monitor and/or predict the progression of T1D and the insurgence of vasculopathies. Future Directions: More mechanistic studies are needed to investigate whether the dysregulation of EVs in T1D patients is solely reflecting the progression of diabetes and related complications, or EVs also directly participate in the disease process, thus pointing to a potential use of EVs as therapeutic targets/tools in T1D. Antioxid. Redox Signal. 36, 631–651. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. CD31+ Extracellular Vesicles From Patients With Type 2 Diabetes Shuttle a miRNA Signature Associated With Cardiovascular Complications.
- Author
-
Prattichizzo, Francesco, De Nigris, Valeria, Sabbatinelli, Jacopo, Giuliani, Angelica, Castaño, Carlos, Párrizas, Marcelina, Crespo, Isabel, Grimaldi, Annalisa, Baranzini, Nicolò, Spiga, Rosangela, Mancuso, Elettra, Rippo, Maria Rita, Procopio, Antonio Domenico, Novials, Anna, Bonfigli, Anna Rita, Garavelli, Silvia, La Sala, Lucia, Matarese, Giuseppe, de Candia, Paola, and Olivieri, Fabiola
- Subjects
EXTRACELLULAR vesicles ,TYPE 2 diabetes ,MICRORNA ,RNA metabolism ,RESEARCH ,DIABETIC cardiomyopathy ,CROSS-sectional method ,RESEARCH methodology ,MEDICAL cooperation ,EVALUATION research ,COMPARATIVE studies ,EPITHELIAL cells - Abstract
Innovative biomarkers are needed to improve the management of patients with type 2 diabetes mellitus (T2DM). Blood circulating miRNAs have been proposed as a potential tool to detect T2DM complications, but the lack of tissue specificity, among other reasons, has hampered their translation to clinical settings. Extracellular vesicle (EV)-shuttled miRNAs have been proposed as an alternative approach. Here, we adapted an immunomagnetic bead-based method to isolate plasma CD31+ EVs to harvest vesicles deriving from tissues relevant for T2DM complications. Surface marker characterization showed that CD31+ EVs were also positive for a range of markers typical of both platelets and activated endothelial cells. After characterization, we quantified 11 candidate miRNAs associated with vascular performance and shuttled by CD31+ EVs in a large (n = 218) cross-sectional cohort of patients categorized as having T2DM without complications, having T2DM with complications, and control subjects. We found that 10 of the tested miRNAs are affected by T2DM, while the signature composed by miR-146a, -320a, -422a, and -451a efficiently identified T2DM patients with complications. Furthermore, another CD31+ EV-shuttled miRNA signature, i.e., miR-155, -320a, -342-3p, -376, and -422a, detected T2DM patients with a previous major adverse cardiovascular event. Many of these miRNAs significantly correlate with clinical variables held to play a key role in the development of complications. In addition, we show that CD31+ EVs from patients with T2DM are able to promote the expression of selected inflammatory mRNAs, i.e., CCL2, IL-1α, and TNFα, when administered to endothelial cells in vitro. Overall, these data suggest that the miRNA cargo of plasma CD31+ EVs is largely affected by T2DM and related complications, encouraging further research to explore the diagnostic potential and the functional role of these alterations. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. Blood Co-Circulating Extracellular microRNAs and Immune Cell Subsets Associate with Type 1 Diabetes Severity.
- Author
-
Garavelli, Silvia, Bruzzaniti, Sara, Tagliabue, Elena, Prattichizzo, Francesco, Silvestre, Dario Di, Perna, Francesco, Sala, Lucia La, Ceriello, Antonio, Mozzillo, Enza, Fattorusso, Valentina, Mauri, Pierluigi, Puca, Annibale A., Franzese, Adriana, Matarese, Giuseppe, Galgani, Mario, and Candia, Paola de
- Subjects
- *
TYPE 1 diabetes , *B cells , *GLYCOSYLATED hemoglobin , *DIABETIC acidosis , *GLYCEMIC control , *INSULIN aspart , *T helper cells - Abstract
Immune cell subsets and microRNAs have been independently proposed as type 1 diabetes (T1D) diagnostic and/or prognostic biomarkers. Here, we aimed to analyze the relationships between peripheral blood circulating immune cell subsets, plasmatic microRNAs, and T1D. Blood samples were obtained from both children with T1D at diagnosis and age-sex matched healthy controls. Then, immunophenotype assessed by flow cytometry was coupled with the quantification of 60 plasmatic microRNAs by quantitative RT-PCR. The associations between immune cell frequency, plasmatic microRNAs, and the parameters of pancreatic loss, glycemic control, and diabetic ketoacidosis were assessed by logistic regression models and correlation analyses. We found that the increase in specific plasmatic microRNAs was associated with T1D disease onset (let-7c-5p, let-7d-5p, let-7f-5p, let-7i-5p, miR-146a-5p, miR-423-3p, and miR-423-5p), serum C-peptide concentration (miR-142-5p and miR-29c-3p), glycated hemoglobin (miR-26a-5p and miR-223-3p) and the presence of ketoacidosis (miR-29c-3p) more strongly than the evaluated immune cell subset frequency. Some of these plasmatic microRNAs were shown to positively correlate with numbers of blood circulating B lymphocytes (miR-142-5p) and CD4+CD45RO+ (miR-146a-5p and miR-223-3p) and CD4+CD25+ cells (miR-423-3p and miR-223-3p) in children with T1D but not in healthy controls, suggesting a disease-specific microRNA association with immune dysregulation in T1D. In conclusion, our results suggest that, while blood co-circulating extracellular microRNAs and immune cell subsets may be biologically linked, microRNAs may better provide powerful information about T1D onset and severity. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
7. Metabolism and Autoimmune Responses: The microRNA Connection.
- Author
-
Colamatteo, Alessandra, Micillo, Teresa, Bruzzaniti, Sara, Fusco, Clorinda, Garavelli, Silvia, De Rosa, Veronica, Galgani, Mario, Spagnuolo, Maria Immacolata, Di Rella, Francesca, Puca, Annibale A., de Candia, Paola, and Matarese, Giuseppe
- Subjects
MICRORNA ,MESSENGER RNA ,T cells ,NON-coding RNA ,METABOLISM ,ONTOGENY ,AUTOIMMUNITY ,AUTOIMMUNE diseases ,CELL physiology - Abstract
Distinct metabolic pathways are known to regulate growth, differentiation, survival, and activation of immune cells by providing energy and specific biosynthetic precursors. Compelling experimental evidence demonstrates that effector T cell functions are coupled with profound changes in cellular metabolism. Importantly, the effector T cell-dependent "anti-self" response characterizing the autoimmune diseases is accompanied by significant metabolic alterations. MicroRNAs (miRNAs), evolutionary conserved small non-coding RNA molecules that affect gene expression by binding to target messenger RNAs, are now known to regulate multiple functions of effector T cells, including the strength of their activation, thus contributing to immune homeostasis. In this review, we will examine the most recent studies that describe miRNA direct involvement in the metabolic reprogramming that marks effector T cell functions. In particular, we will focus on the work showing a connection between miRNA regulatory function and the molecular network dysregulation that leads to metabolic pathway derangement in autoimmunity. Finally, we will also speculate on the possibility that the interplay between miRNAs and metabolism in T cells may help identify novel miRNA-based therapeutic strategies to treat effector T cell immunometabolic alterations in pathological conditions such as autoimmunity and chronic inflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
8. Type 2 Diabetes: How Much of an Autoimmune Disease?
- Author
-
de Candia, Paola, Prattichizzo, Francesco, Garavelli, Silvia, De Rosa, Veronica, Galgani, Mario, Di Rella, Francesca, Spagnuolo, Maria Immacolata, Colamatteo, Alessandra, Fusco, Clorinda, Micillo, Teresa, Bruzzaniti, Sara, Ceriello, Antonio, Puca, Annibale A., and Matarese, Giuseppe
- Subjects
TYPE 2 diabetes ,AUTOIMMUNE diseases ,T cells ,IMMUNE response ,NATURAL immunity - Abstract
Type 2 diabetes (T2D) is characterized by a progressive status of chronic, low-grade inflammation (LGI) that accompanies the whole trajectory of the disease, from its inception to complication development. Accumulating evidence is disclosing a long list of possible "triggers" of inflammatory responses, many of which are promoted by unhealthy lifestyle choices and advanced age. Diabetic patients show an altered number and function of immune cells, of both innate and acquired immunity. Reactive autoantibodies against islet antigens can be detected in a subpopulation of patients, while emerging data are also suggesting an altered function of specific T lymphocyte populations, including T regulatory (Treg) cells. These observations led to the hypothesis that part of the inflammatory response mounting in T2D is attributable to an autoimmune phenomenon. Here, we review recent data supporting this framework, with a specific focus on both tissue resident and circulating Treg populations. We also propose that selective interception (or expansion) of T cell subsets could be an alternative avenue to dampen inappropriate inflammatory responses without compromising immune responses. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
9. PI3K/AKT signaling inhibits NOTCH1 lysosome-mediated degradation.
- Author
-
Platonova, Natalia, Manzo, Teresa, Mirandola, Leonardo, Colombo, Michela, Calzavara, Elisabetta, Vigolo, Emilia, Cermisoni, Greta Chiara, De Simone, Daria, Garavelli, Silvia, Cecchinato, Valentina, Lazzari, Elisa, Neri, Antonino, and Chiaramonte, Raffaella
- Published
- 2015
- Full Text
- View/download PDF
10. Does microRNA Perturbation Control the Mechanisms Linking Obesity and Diabetes? Implications for Cardiovascular Risk.
- Author
-
La Sala, Lucia, Crestani, Maurizio, Garavelli, Silvia, de Candia, Paola, and Pontiroli, Antonio E.
- Subjects
NON-coding RNA ,MICRORNA ,CARDIOVASCULAR diseases risk factors ,TYPE 2 diabetes ,ADIPOSE tissues ,METABOLIC disorders ,SKELETAL muscle - Abstract
Metabolic disorders such as obesity and type 2 diabetes (T2D) are considered the major risk factors for the development of cardiovascular diseases (CVD). Although the pathological mechanisms underlying the mutual development of obesity and T2D are difficult to define, a better understanding of the molecular aspects is of utmost importance to identify novel therapeutic targets. Recently, a class of non-coding RNAs, called microRNAs (miRNAs), are emerging as key modulators of metabolic abnormalities. There is increasing evidence supporting the role of intra- and extracellular miRNAs as determinants of the crosstalk between adipose tissues, liver, skeletal muscle and other organs, triggering the paracrine communication among different tissues. miRNAs may be considered as risk factors for CVD due to their correlation with cardiovascular events, and in particular, may be related to the most prominent risk factors. In this review, we describe the associations observed between miRNAs expression levels and the most common cardiovascular risk factors. Furthermore, we sought to depict the molecular aspect of the interplay between obesity and diabetes, investigating the role of microRNAs in the interorgan crosstalk. Finally, we discussed the fascinating hypothesis of the loss of protective factors, such as antioxidant defense systems regulated by such miRNAs. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Extracellular Vesicles from Skeletal Muscle Cells Efficiently Promote Myogenesis in Induced Pluripotent Stem Cells.
- Author
-
Baci, Denisa, Chirivì, Maila, Pace, Valentina, Maiullari, Fabio, Milan, Marika, Rampin, Andrea, Somma, Paolo, Presutti, Dario, Garavelli, Silvia, Bruno, Antonino, Cannata, Stefano, Lanzuolo, Chiara, Gargioli, Cesare, Rizzi, Roberto, and Bearzi, Claudia
- Subjects
MYOBLASTS ,INDUCED pluripotent stem cells ,EXTRACELLULAR vesicles ,MUSCLE cells ,SKELETAL muscle ,SATELLITE cells - Abstract
The recent advances, offered by cell therapy in the regenerative medicine field, offer a revolutionary potential for the development of innovative cures to restore compromised physiological functions or organs. Adult myogenic precursors, such as myoblasts or satellite cells, possess a marked regenerative capacity, but the exploitation of this potential still encounters significant challenges in clinical application, due to low rate of proliferation in vitro, as well as a reduced self-renewal capacity. In this scenario, induced pluripotent stem cells (iPSCs) can offer not only an inexhaustible source of cells for regenerative therapeutic approaches, but also a valuable alternative for in vitro modeling of patient-specific diseases. In this study we established a reliable protocol to induce the myogenic differentiation of iPSCs, generated from pericytes and fibroblasts, exploiting skeletal muscle-derived extracellular vesicles (EVs), in combination with chemically defined factors. This genetic integration-free approach generates functional skeletal myotubes maintaining the engraftment ability in vivo. Our results demonstrate evidence that EVs can act as biological "shuttles" to deliver specific bioactive molecules for a successful transgene-free differentiation offering new opportunities for disease modeling and regenerative approaches. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.